Bluebird bio appoints new CFO
May 29 (Reuters) - Gene therapy maker bluebird bio BLUE.O said on Wednesday it has appointed James Sterling as chief financial officer (CFO), effective June 10. (Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli) ((Mariam.ESunny@thomsonreuters.com;))
Recent news on bluebird bio
See all newsBrief: Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital
Brief: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
Brief: Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment